Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL6996827

CC(C)(C)OC(=O)N1CCC(O)(C#CCO)CC1.CCCC[N+](CCCC)(CCCC)CCCC.[F-]

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 3/20 0.37
ADAM17 P78536 3/20 0.37
MMP2 P08253 2/20 0.37
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SPHK1 Q9NYA1 1/20 0.34
CNR2 P34972 1/20 0.33
TLR8 Q9NR97 1/20 0.33
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR3 P22607 1/20 0.33
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
ATM Q13315 1/20 0.32
GPR4 P46093 1/20 0.32
NR1H2 P55055 1/20 0.32
MMP14 P50281 1/20 0.32
GPR119 Q8TDV5 3/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4690324 0.87 USP2 (0.44) MMP13ADAM17MMP2USP2SMN1; SMN2
Tetrabuthylammonium SCHEMBL28155000 0.76 HPGD (0.50) USP2SMN1; SMN2CNR2PDE4APDE4B
Tetrabuthylammonium SCHEMBL28285724 0.76 HPGD (0.47) USP2SMN1; SMN2CNR2PDE4APDE4B
Tetrabuthylammonium SCHEMBL28284119 0.75 HPGD (0.52) USP2SMN1; SMN2CNR2
SCHEMBL28675542 0.74 USP2 (0.42) MMP13ADAM17MMP2USP2SMN1; SMN2
SCHEMBL6229408 0.73 MMP13 (0.35) MMP13ADAM17MMP2USP2SMN1; SMN2
Tetrabuthylammonium SCHEMBL28155004 0.73 USP2 (0.43) USP2SMN1; SMN2SPHK1CNR2TLR8
SCHEMBL2892960 0.72 USP2 (0.47) MMP13ADAM17MMP2USP2SMN1; SMN2
SCHEMBL4692388 0.72 USP2 (0.42) MMP13ADAM17USP2SMN1; SMN2FGFR1
SCHEMBL4836593 0.72 GPR4 (0.45) USP2SMN1; SMN2SPHK1CNR2GPR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1286967-A1 CYCLOHEXANE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LTD. (GB) 2003-03-05 EP disclosed
WO-2001087838-A1 CYCLOHEXANE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 2001-11-22 WO disclosed